Cleo Diagnostics Ltd (ASX:COV)
Australia
· Delayed Price · Currency is AUD 0.505
-0.035 (-6.48%)
At close: Mar 9, 2026
Cleo Diagnostics Market Cap
Cleo Diagnostics has a market cap or net worth of 69.12 million as of March 9, 2026. Its market cap has increased by 2.45% in one year.
Market Cap
69.12M
Enterprise Value
59.69M
Revenue
2.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.51
Market Cap Chart
Since August 15, 2023, Cleo Diagnostics's market cap has increased from 25.70M to 69.12M, an increase of 168.93%. That is a compound annual growth rate of 47.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 69.12M | -16.53% |
| Dec 31, 2025 | 82.80M | 81.51% |
| Dec 31, 2024 | 45.62M | 102.86% |
| Dec 29, 2023 | 22.49M | -12.50% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Compumedics | 59.93M |
| Micro-X | 47.77M |
| CleanSpace Holdings | 42.59M |
| HeraMED | 42.32M |
| Nova Eye Medical | 41.30M |
| ImpediMed | 34.66M |
| SomnoMed | 141.99M |
| EMVision Medical Devices | 146.84M |